share_log

Virpax Pharmaceuticals Q2 EPS $(0.50) Down From $(0.47) YoY

Benzinga Real-time News ·  Aug 15, 2022 09:06

Virpax Pharmaceuticals (NASDAQ:VRPX) reported quarterly losses of $(0.50) per share. This is a 6.38 percent decrease over losses of $(0.47) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment